Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Corneal Higher-Order Aberrations in Descemet Membrane Endothelial Keratoplasty versus Ultrathin DSAEK in the Descemet Endothelial Thickness Comparison Trial: A Randomized Clinical Trial.

Duggan MJ, Rose-Nussbaumer J, Lin CC, Austin A, Labadzinzki PC, Chamberlain WD.

Ophthalmology. 2019 Jul;126(7):946-957. doi: 10.1016/j.ophtha.2019.02.007. Epub 2019 Feb 16.

PMID:
30776384
2.

Lung Protective Effects of Low-Volume Resuscitation and Pharmacologic Treatment of Swine Subjected to Polytrauma and Hemorrhagic Shock.

Nikolian VC, Pan B, Mesar T, Dennahy IS, Georgoff PE, Duan X, Liu B, Wu X, Duggan MJ, Alam HB, Li Y.

Inflammation. 2017 Aug;40(4):1264-1274. doi: 10.1007/s10753-017-0569-6.

PMID:
28493077
3.

An injectable shear-thinning biomaterial for endovascular embolization.

Avery RK, Albadawi H, Akbari M, Zhang YS, Duggan MJ, Sahani DV, Olsen BD, Khademhosseini A, Oklu R.

Sci Transl Med. 2016 Nov 16;8(365):365ra156.

PMID:
27856795
4.

Validation of Respiratory Inductance Plethysmography for Measuring Tidal Volume in Swine.

Su Z, Oto J, Wang J, Kimball WR, Chenelle CT, Kacmarek RM, King DR, Jiang Y, Duggan MJ.

Comp Med. 2015 Jun;65(3):225-31.

5.

Chronic safety assessment of hemostatic self-expanding foam: 90-day survival study and intramuscular biocompatibility.

Rago AP, Duggan MJ, Hannett P, Brennecke LH, LaRochelle A, Khatri C, Zugates GT, Chang Y, Sharma U, King DR.

J Trauma Acute Care Surg. 2015 Oct;79(4 Suppl 2):S78-84. doi: 10.1097/TA.0000000000000571.

PMID:
26131784
6.

Efficacy of a prehospital self-expanding polyurethane foam for noncompressible hemorrhage under extreme operational conditions.

Rago AP, Larentzakis A, Marini J, Picard A, Duggan MJ, Busold R, Helmick M, Zugates G, Beagle J, Sharma U, King DR.

J Trauma Acute Care Surg. 2015 Feb;78(2):324-9. doi: 10.1097/TA.0000000000000507.

PMID:
25757118
7.

Diagnosis and deployment of a self-expanding foam for abdominal exsanguination: Translational questions for human use.

Rago AP, Marini J, Duggan MJ, Beagle J, Runyan G, Sharma U, Peev M, King DR.

J Trauma Acute Care Surg. 2015 Mar;78(3):607-13. doi: 10.1097/TA.0000000000000558.

PMID:
25710434
8.

Self-expanding foam for prehospital treatment of intra-abdominal hemorrhage: 28-day survival and safety.

Rago AP, Duggan MJ, Beagle J, Peev MP, Marini J, Hwabejire JO, Hannett P, Zugates G, Busold R, Helmick M, Velmahos G, Demoya MA, Yeh DD, Fagenholz PJ, Sharma U, King DR.

J Trauma Acute Care Surg. 2014 Sep;77(3 Suppl 2):S127-33. doi: 10.1097/TA.0000000000000380.

PMID:
25159345
9.

Hydrophobically-modified chitosan foam: description and hemostatic efficacy.

Dowling MB, Smith W, Balogh P, Duggan MJ, MacIntire IC, Harris E, Mesar T, Raghavan SR, King DR.

J Surg Res. 2015 Jan;193(1):316-23. doi: 10.1016/j.jss.2014.06.019. Epub 2014 Jun 14.

PMID:
25016441
10.

Self-expanding foam improves survival following a lethal, exsanguinating iliac artery injury.

Rago A, Duggan MJ, Marini J, Beagle J, Velmahos G, De Moya MA, Sharma U, Hwabejire J, King DR.

J Trauma Acute Care Surg. 2014 Jul;77(1):73-7. doi: 10.1097/TA.0000000000000263.

PMID:
24977758
11.

Self-expanding foam for prehospital treatment of severe intra-abdominal hemorrhage: dose finding study.

Peev MP, Rago A, Hwabejire JO, Duggan MJ, Beagle J, Marini J, Zugates G, Busold R, Freyman T, Velmahos GS, Demoya MA, Yeh DD, Fagenholz PJ, Sharma U, King DR.

J Trauma Acute Care Surg. 2014 Mar;76(3):619-23; discussion 623-4. doi: 10.1097/TA.0000000000000126.

PMID:
24553527
12.

Development of a lethal, closed-abdomen, arterial hemorrhage model in noncoagulopathic swine.

Duggan MJ, Rago A, Marini J, Beagle J, Peev M, Velmahos G, Sharma U, King DR.

J Surg Res. 2014 Apr;187(2):536-41. doi: 10.1016/j.jss.2013.12.005. Epub 2013 Dec 12.

PMID:
24398305
13.

Development of a lethal, closed-abdomen grade V hepato-portal injury model in non-coagulopathic swine.

Duggan MJ, Mejaddam AY, Beagle J, Demoya MA, Velmahosa GC, Alam HB, Rago A, Zugates G, Busold R, Freyman T, Sharma U, King DR.

J Surg Res. 2013 Jun 1;182(1):101-7. doi: 10.1016/j.jss.2012.07.048. Epub 2012 Aug 8.

PMID:
22921917
14.

Retargeted clostridial endopeptidases: inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain.

Chaddock JA, Purkiss JR, Alexander FC, Doward S, Fooks SJ, Friis LM, Hall YH, Kirby ER, Leeds N, Moulsdale HJ, Dickenson A, Green GM, Rahman W, Suzuki R, Duggan MJ, Quinn CP, Shone CC, Foster KA.

Mov Disord. 2004 Mar;19 Suppl 8:S42-7.

PMID:
15027053
15.

Inhibition of release of neurotransmitters from rat dorsal root ganglia by a novel conjugate of a Clostridium botulinum toxin A endopeptidase fragment and Erythrina cristagalli lectin.

Duggan MJ, Quinn CP, Chaddock JA, Purkiss JR, Alexander FC, Doward S, Fooks SJ, Friis LM, Hall YH, Kirby ER, Leeds N, Moulsdale HJ, Dickenson A, Green GM, Rahman W, Suzuki R, Shone CC, Foster KA.

J Biol Chem. 2002 Sep 20;277(38):34846-52. Epub 2002 Jul 8.

16.
17.

Inhibition of vesicular secretion in both neuronal and nonneuronal cells by a retargeted endopeptidase derivative of Clostridium botulinum neurotoxin type A.

Chaddock JA, Purkiss JR, Friis LM, Broadbridge JD, Duggan MJ, Fooks SJ, Shone CC, Quinn CP, Foster KA.

Infect Immun. 2000 May;68(5):2587-93.

18.
19.

Development of a syngeneic bovine fibroblast cell line: implications for the study of bovine cytotoxic T lymphocytes.

Hegde NR, Lewin HA, Duggan MJ, Stabel JR, Srikumaran S.

Viral Immunol. 1998;11(1):37-48.

PMID:
9586696
20.

The effect of botulinum neurotoxins on the release of insulin from the insulinoma cell lines HIT-15 and RINm5F.

Boyd RS, Duggan MJ, Shone CC, Foster KA.

J Biol Chem. 1995 Aug 4;270(31):18216-8.

21.

Design, synthesis, and in vitro activity of bis(succinimido)hexane peptide heterodimers with combined B1 and B2 antagonist activity.

Cheronis JC, Whalley ET, Allen LG, Loy SD, Elder MW, Duggan MJ, Gross KL, Blodgett JK.

J Med Chem. 1994 Feb 4;37(3):348-55.

PMID:
8308862
22.

Orphan seven transmembrane domain receptors: reversing pharmacology.

Mills A, Duggan MJ.

Trends Biotechnol. 1994 Feb;12(2):47-9. Review.

PMID:
7764535
23.

Orphan seven transmembrane domain receptors: reversing pharmacology.

Mills A, Duggan MJ.

Trends Pharmacol Sci. 1993 Nov;14(11):394-6. Review. No abstract available.

PMID:
8296395
24.
25.

A new class of bradykinin antagonists: synthesis and in vitro activity of bissuccinimidoalkane peptide dimers.

Cheronis JC, Whalley ET, Nguyen KT, Eubanks SR, Allen LG, Duggan MJ, Loy SD, Bonham KA, Blodgett JK.

J Med Chem. 1992 May 1;35(9):1563-72.

PMID:
1578482
26.
29.

Lipoprotein associated coagulation inhibitor, factor VII, antithrombin III, and monocyte tissue factor following surgery.

Carson SD, Haire WD, Broze GJ Jr, Novotny WF, Pirrucello SJ, Duggan MJ.

Thromb Haemost. 1991 Nov 1;66(5):534-9.

PMID:
1803617
30.

Immunoblastic lymphoma with abundant clear cytoplasm. A comparative study of B- and T-cell types.

Nakamine H, Masih AS, Strobach RS, Duggan MJ, Bast MA, Armitage JO, Weisenburger DD.

Am J Clin Pathol. 1991 Aug;96(2):177-83.

PMID:
1862772
31.

Non-Hodgkin's lymphomas of mantle zone origin.

Weisenburger DD, Duggan MJ, Perry DA, Sanger WG, Armitage JO.

Pathol Annu. 1991;26 Pt 1:139-58. Review. No abstract available.

PMID:
2014138
33.

Mantle zone lymphoma. A clinicopathologic study of 22 cases.

Duggan MJ, Weisenburger DD, Ye YL, Bast MA, Pierson JL, Linder J, Armitage JO.

Cancer. 1990 Aug 1;66(3):522-9.

PMID:
2364363
34.

Biochemical evidence for the existence of gamma-aminobutyrateA receptor iso-oligomers.

Duggan MJ, Stephenson FA.

J Biol Chem. 1990 Mar 5;265(7):3831-5.

37.

Identification of the alpha 3-subunit in the GABAA receptor purified from bovine brain.

Stephenson FA, Duggan MJ, Casalotti SO.

FEBS Lett. 1989 Jan 30;243(2):358-62.

38.

Bone marrow findings in immunodeficiency syndromes.

Duggan MJ, Weisenburger DD, Sun NC, Purtilo DT.

Hematol Oncol Clin North Am. 1988 Dec;2(4):637-56. Review.

PMID:
3065323
39.

Benzodiazepine binding site heterogeneity in the purified GABAA receptor.

Duggan MJ, Stephenson FA.

Eur J Pharmacol. 1988 Sep 23;154(3):293-8.

PMID:
2853059
40.

Bone marrow patterns in aplastic anemia: observations with 1.5-T MR imaging.

Kaplan PA, Asleson RJ, Klassen LW, Duggan MJ.

Radiology. 1987 Aug;164(2):441-4.

PMID:
3602384
41.

Collagen-binding of von Willebrand's factor antigen in the classification of von Willebrand's disease.

Duggan MJ, DiMichele DM, Christian MJ, Fink LM, Hathaway WE.

Am J Clin Pathol. 1987 Jul;88(1):97-102.

PMID:
3496781
42.

Familial aortic dissection in absence of ascending aortic aneurysms: a lethal syndrome associated with precocious systemic hypertension.

McManus BM, Cassling RS, Soundy TJ, Wilson JE, Sears TD, Rogler WC, Buehler BA, Wolford JF, Duggan MJ, Byers PH, et al.

Am J Cardiovasc Pathol. 1987 Jan;1(1):55-67.

PMID:
3455236
43.

Lead pollution from the external redecoration of old buildings.

Rundle SA, Duggan MJ.

Sci Total Environ. 1986 Dec 1;57:181-90.

PMID:
3810141
44.

Within-laboratory quality control of asbestos counting.

Ogden TL, Shenton-Taylor T, Cherrie JW, Crawford NP, Moorcroft S, Duggan MJ, Jackson PA, Treble RD.

Ann Occup Hyg. 1986;30(4):411-25. No abstract available.

PMID:
3813348
45.

Lead in playground dust and on the hands of schoolchildren.

Duggan MJ, Inskip MJ, Rundle SA, Moorcroft JS.

Sci Total Environ. 1985 Jul;44(1):65-79.

PMID:
4023696
46.

Childhood exposure to lead in surface dust and soil: a community health problem.

Duggan MJ, Inskip MJ.

Public Health Rev. 1985;13(1-2):1-54. Review. No abstract available.

PMID:
2422703
47.

Rate of decline of asbestos fibre concentration in room air.

Moorcroft JS, Duggan MJ.

Ann Occup Hyg. 1984;28(4):453-7. No abstract available.

PMID:
6529076
48.

The uptake and excretion of lead by young children.

Duggan MJ.

Arch Environ Health. 1983 Jul-Aug;38(4):246-7.

PMID:
6615006
49.

Contribution of lead in dust to children's blood lead.

Duggan MJ.

Environ Health Perspect. 1983 Apr;50:371-81.

50.

Synthesis and biological properties of 2'-deoxy-5-vinyluridine and 2'deoxy-5-vinylcytidine.

Rahim SG, Duggan MJ, Walker RT, Jones AS, Dyer RL, Balzarini J, De Clercq E.

Nucleic Acids Res. 1982 Sep 11;10(17):5285-95.

Supplemental Content

Loading ...
Support Center